Concepción Boqué

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus et al. · New England Journal of Medicine · 2010 · 1.6K citations

Medicine, Pharmacology, Pharmacotherapy +10

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

Jörge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian et al. · Journal of Clinical Oncology · 2016 · 946 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)

Elias Jabbour, Hagop M. Kantarjian, Giuseppe Saglio et al. · Blood · 2013 · 391 citations · Full text

Medicine, Hematology, Oncology +8

Cadherin-13, a Mediator of Calcium-Dependent Cell-Cell Adhesion, Is Silenced by Methylation in Chronic Myeloid Leukemia and Correlates With Pretreatment Risk Profile and Cytogenetic Response to Interferon Alfa

José Román‐Gómez, Juan A. Castillejo, Antonio Jiménez et al. · Journal of Clinical Oncology · 2003 · 96 citations

Medicine, Hematology, Oncology +17

Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

Alberto Álvarez‐Larrán, Manuel Pérez‐Encinas, Francisca Ferrer‐Marín et al. · Haematologica · 2016 · 74 citations · Full text

Medicine, Hematology, Pharmacotherapy +11